General form of registration statement for all companies including face-amount certificate companies

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.10.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Sep. 04, 2018
Nov. 14, 2017
Jun. 24, 2016
Dec. 20, 2013
Mar. 31, 2017
Jan. 31, 2017
Dec. 31, 2016
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Feb. 28, 2017
Mr. Andrew I. Sealfon [Member]                          
Officer compensation $ 325,000                        
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]                          
Lease payments               $ 1,292 $ 3,876 $ 9,045 $ 13,128 $ 13,421 $ 21,500
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]                          
Monthly lease payments   $ 12,088           11,042 11,042     11,042  
Lease payments               33,126 33,126 99,378 99,378 110,420 132,504
Property taxes paid               12,431 12,862 37,863 37,447 41,959 48,455
Brad A. Sealfon [Member]                          
Officer compensation         $ 2,000 $ 7,744 $ 7,744            
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Mark Baker [Member]                          
Amortization of deferred compensation cost               0 0 0 7,000 $ 0 28,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Mark Baker [Member]                          
Number of shares issued upon agreement       420,000                  
Share price (in dollars per share)       $ 0.20                  
Agreement term       3 years                  
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]                          
Monthly payment for agreement     $ 16,000                    
Number of shares repurchased                       96,542  
Value of shares repurchased                       $ 43,393  
Officer compensation               $ 0 $ 0 $ 0 $ 16,000   $ 230,000